Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Carcinoma and FTO[original query] |
---|
The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PloS one 2011 6 (2): e16756. Lurie Galina, Gaudet Mia M, Spurdle Amanda B, Carney Michael E, Wilkens Lynne R, Yang Hannah P, Weiss Noel S, Webb Penelope M, Thompson Pamela J, Terada Keith, Setiawan Veronica Wendy, Rebbeck Timothy R, Prescott Jennifer, Orlow Irene, O'Mara Tracy, Olson Sara H, Narod Steven A, Matsuno Rayna K, Lissowska Jolanta, Liang Xiaolin, Levine Douglas A, Le Marchand Loic, Kolonel Laurence N, Henderson Brian E, Garcia-Closas Montserrat, Doherty Jennifer Anne, De Vivo Immaculata, Chen Chu, Brinton Louise A, Akbari Mohammad R, , , Goodman Marc |
A polymorphism at the 3'-UTR region of the aromatase gene is associated with the efficacy of the aromatase inhibitor, anastrozole, in metastatic breast carcinoma. International journal of molecular sciences 2013 14 (9): 18973-88. Liu Lei, Bai Yu-Xian, Zhou Jian-Hua, Sun Xiu-Wei, Sui Hong, Zhang Wen-Jie, Yuan Heng-Heng, Xie Rui, Wei Xiao-Li, Zhang Ting-Ting, Huang Peng, Li Yan-Jing, Wang Jing-Xuan, Zhao Shu, Zhang Qing-Yu |
A Comprehensive Meta-analysis of Case-Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016 Feb . Figlioli Gisella, Elisei Rossella, Romei Cristina, Melaiu Ombretta, Cipollini Monica, Bambi Franco, Chen Bowang, Köhler Aleksandra, Cristaudo Alfonso, Hemminki Kari, Gemignani Federica, Försti Asta, Landi Stefa |
N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization. Archives of toxicology 2021 3 95 (5): 1621-1629. Liu Jiandong, Wang Dongyang, Zhou Jianyuan, Wang Leirong, Zhang Nasha, Zhou Liqing, Zeng Jiajia, Liu Jibing, Yang Mi |
FTO Gene Polymorphisms Contribute to the Predisposition and Radiotherapy Efficiency of Nasopharyngeal Carcinoma [Retraction]. Pharmacogenomics and personalized medicine 2021 12 14 1601-1602. Authors are not available |
Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker. International journal of general medicine 2021 11 14 7411-7422. Zhao Chengwen, Liu Yonghui, Ju Shaoqing, Wang Xudo |
An integrated model of FTO and METTL3 expression that predicts prognosis in lung squamous cell carcinoma patients. Annals of translational medicine 2021 11 9 (20): 1523. Zhang Kun, Han Zhaojie, Zhao Hongmei, Liu Siyao, Zeng Fuch |
FTO Gene Polymorphisms Contribute to the Predisposition and Radiotherapy Efficiency of Nasopharyngeal Carcinoma. Pharmacogenomics and personalized medicine 2021 14 1239-1245. Xiao Feng, Zhou Jianro |
Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease. Nature genetics 2023 9 . Yanhua Chen, Xiaomeng Du, Annapurna Kuppa, Mary F Feitosa, Lawrence F Bielak, Jeffrey R O'Connell, Solomon K Musani, Xiuqing Guo, Bratati Kahali, Vincent L Chen, Albert V Smith, Kathleen A Ryan, Gudny Eirksdottir, Matthew A Allison, Donald W Bowden, Matthew J Budoff, John Jeffrey Carr, Yii-Der I Chen, Kent D Taylor, Antonino Oliveri, Adolfo Correa, Breland F Crudup, Sharon L R Kardia, Thomas H Mosley, Jill M Norris, James G Terry, Jerome I Rotter, Lynne E Wagenknecht, Brian D Halligan, Kendra A Young, John E Hokanson, George R Washko, Vilmundur Gudnason, Michael A Province, Patricia A Peyser, Nicholette D Palmer, Elizabeth K Speliot |
- Page last reviewed:Feb 1, 2024
- Content source: